Patents by Inventor Wesley Peter

Wesley Peter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210034694
    Abstract: Techniques are disclosed relating to providing a web application capable of executing within a particular web browser or a client application native to a client platform. The particular web browser and the client platform support differing sets of features. A server computer system hosts the web application for distributing to instances of the client application. The server computer system receives, from a particular instance of the client application that is executing on a client device that implements the client platform, a request for the web application. The server computer system sends the web application to the particular instance to cause the web application to be executed within the particular instance. Such execution of the web application permits the web application to use at least one feature not supported by the particular web browser.
    Type: Application
    Filed: July 31, 2019
    Publication date: February 4, 2021
    Inventor: Wesley Peter
  • Patent number: 10761904
    Abstract: Technologies are provided for synchronizing and joining multiple calls from a first thread and one or more second threads to execute a particular code segment. In response to a call from the first thread to execute the particular code segment, a task synchronizer module calls the particular code segment on behalf of the first thread. When execution of the particular code segment starts, and a call is received from a second thread to execute the particular code segment after receiving the call from the first thread, the task synchronizer module suspends execution of the particular code segment so that the second thread awaits for the execution of the particular code segment on behalf of the first thread to complete. When execution completes, a result value or exception is stored in a task object, and the second thread can read the result value or the exception.
    Type: Grant
    Filed: January 17, 2018
    Date of Patent: September 1, 2020
    Assignee: salesforce.com, inc.
    Inventors: Wesley Peter, Avi Brenner, Justin Horst
  • Publication number: 20200184388
    Abstract: A method for managing oilfield water. Oilfield water data is grouped into discrete and non-overlapping groups. Outliers are removed from the data. Features of the remaining data are analyzed to identify most discriminative feature. The data is separated into training data and testing data, and the training data is fit into a model that shows the best precision, accuracy and recall. The model is confirmed using the testing data. Upon confirmation of the accuracy of the model, the model is applied to data for a new proposed oilfield well, and a new proposed project is implemented or disapproved based on a result of the identified model that predicts water production of the new proposed oilfield well.
    Type: Application
    Filed: February 14, 2020
    Publication date: June 11, 2020
    Inventors: Forrest Charles WEBB, Wesley Peter CLEVELAND
  • Patent number: 10565540
    Abstract: A method for managing oilfield water. Oilfield water data is grouped into discrete and non-overlapping groups. Outliers are removed from the data. Features of the remaining data are analyzed to identify most discriminative feature. The data is separated into training data and testing data, and the training data is fit into a model that shows the best precision, accuracy and recall. The model is confirmed using the testing data. Upon confirmation of the accuracy of the model, the model is applied to data for a new proposed oilfield well, and a new proposed project is implemented or disapproved based on a result of the identified model that predicts water production of the new proposed oilfield well.
    Type: Grant
    Filed: August 27, 2015
    Date of Patent: February 18, 2020
    Assignee: SOURCEWATER, INC.
    Inventors: Forrest Charles Webb, Wesley Peter Cleveland
  • Patent number: 10155259
    Abstract: The invention relates to FSH receptor antagonist according to general formula I or a pharmaceutically acceptable salt thereof and to a pharmaceutical composition containing the same. The compounds can be used for the treatment and prevention of endometriosis, for the treatment and prevention of pre-menopausal and peri-menopausal hormone-dependent breast cancer, for contraception, and for the treatment of uterine fibroids and other menstrual-related disorders.
    Type: Grant
    Filed: July 29, 2015
    Date of Patent: December 18, 2018
    Assignee: Merck Sharp & Dohme B.V.
    Inventors: Wesley Peter Blackaby, Martin De Kort, Mark Enthoven, Paul Stuart Hinchliffe, Christian Bernard Matthijs Poulie, Cornelis Marius Timmers, Saskia Verkaik
  • Patent number: 9470522
    Abstract: Systems and methods for updating a scale of a barometric altimeter on aircraft are provided. The method, for example, may include, but is not limited to, receiving, by an aircraft communication system, barometric altimeter scale data corresponding to an atmospheric pressure at an airport, determining, by the processor, if the altitude of the aircraft is below a transition level for the airport, and adjusting, by the processor, the scale of the barometric altimeter based upon the received barometric altimeter scale data when the altitude of the aircraft is below the transition level for the airport.
    Type: Grant
    Filed: February 28, 2012
    Date of Patent: October 18, 2016
    Assignee: HONEYWELL INTERNATIONAL INC.
    Inventors: Wesley Peter, Sabu Mathew
  • Publication number: 20160063402
    Abstract: A method for managing oilfield water. Oilfield water data is grouped into discrete and non-overlapping groups. Outliers are removed from the data. Features of the remaining data are analyzed to identify most discriminative feature. The data is separated into training data and testing data, and the training data is fit into a model that shows the best precision, accuracy and recall. The model is confirmed using the testing data. Upon confirmation of the accuracy of the model, the model is applied to data for a new proposed oilfield well, and a new proposed project is implemented or disapproved based on a result of the identified model that predicts water production of the new proposed oilfield well.
    Type: Application
    Filed: August 27, 2015
    Publication date: March 3, 2016
    Applicant: DIGITAL H2O, INC.
    Inventors: Forrest Charles WEBB, Wesley Peter CLEVELAND
  • Publication number: 20150329545
    Abstract: The invention relates to FSH receptor antagonist according to general formula I or a pharmaceutically acceptable salt thereof and to a pharmaceutical composition containing the same. The compounds can be used for the treatment and prevention of endometriosis, for the treatment and prevention of pre-menopausal and peri-menopausal hormone-dependent breast cancer, for contraception, and for the treatment of uterine fibroids and other menstrual-related disorders.
    Type: Application
    Filed: July 29, 2015
    Publication date: November 19, 2015
    Inventors: Wesley Peter Blackaby, Martin De Kort, Mark Enthoven, Paul Stuart Hinchliffe, Christian Bernard Matthijs Poulie, Cornelis Marius Timmers, Saskia Verkaik
  • Patent number: 9127007
    Abstract: The invention relates to FSH receptor antagonist according to general formula (I) or a pharmaceutically acceptable salt thereof and to a pharmaceutical composition containing the same. The compounds can be used for the treatment and prevention of endometriosis, for the treatment and prevention of pre-menopausal and peri-menopausal hormone-dependent breast cancer, for contraception, and for the treatment of uterine fibroids and other menstrual-related disorders.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: September 8, 2015
    Assignee: Merck Sharp & Dohme B.V.
    Inventors: Wesley Peter Blackaby, Martin De Kort, Mark Enthoven, Paul Stuart Hinchliffe, Christian Bernard Matthijs Poulie, Cornelis Marius Timmers, Saskia Verkaik
  • Patent number: 9044463
    Abstract: The invention relates to FSH receptor antagonist according to general formula I or a pharmaceutically acceptable salt thereof and to a pharmaceutical composition containing the same. The compounds can be used for the treatment and prevention of endometriosis, for the treatment and prevention of pre-menopausal and peri-menopausal hormone-dependent breast cancer, for contraception, and for the treatment of uterine fibroids and other menstrual-related disorders.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: June 2, 2015
    Assignee: Merck Sharp & Dohme B.V.
    Inventors: Wesley Peter Blackaby, Martin De Kort, Mark Enthoven, Paul Stuart Hinchliffe, Cristian Bernard Matthijs Poulie, Cornelis Marius Timmers, Saskia Verkaik
  • Patent number: 8993757
    Abstract: The invention relates to a N-piperidin-4-yl derivative having the general Formula I or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising the same and to the use of said N-piperidin-4-yl derivatives for the treatment and prevention of endometriosis, for the treatment and prevention of pre-menopausal and peri-menopausal hormone-dependent breast cancer, for contraception, or for the treatment of uterine fibroids or other menstrual-related disorders.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: March 31, 2015
    Assignee: Merck Sharp & Dohme B.V.
    Inventors: Ines Huisman, Marcelis Van Der Stelt, Wouter Wiedenhof, Charles Anthony Graham Baker-Glenn, Wesley Peter Blackaby, Naimisha Trivedi
  • Publication number: 20140350043
    Abstract: The invention relates to FSH receptor antagonist according to general formula (I) or a pharmaceutically acceptable salt thereof and to a pharmaceutical composition containing the same. The compounds can be used for the treatment and prevention of endometriosis, for the treatment and prevention of pre-menopausal and peri-menopausal hormone-dependent breast cancer, for contraception, and for the treatment of uterine fibroids and other menstrual-related disorders.
    Type: Application
    Filed: September 14, 2012
    Publication date: November 27, 2014
    Inventors: Wesley Peter Blackaby, Martin De Kort, Mark Enthoven, Paul Stuart Hinchliffe, Christian Bernard Matthijs Poulie, Cornelis Marius Timmers, Saskia Verkaik
  • Publication number: 20140329822
    Abstract: The invention relates to a N-piperidin-4-yl derivative having the general Formula I or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising the same and to the use of said N-piperidin-4-yl derivatives for the treatment and prevention of endometriosis, for the treatment and prevention of pre-menopausal and peri-menopausal hormone-dependent breast cancer, for contraception, or for the treatment of uterine fibroids or other menstrual-related disorders.
    Type: Application
    Filed: September 14, 2012
    Publication date: November 6, 2014
    Inventors: Ines Huisman, Marcelis Van Der Stelt, Wouter Wiedenhof, Charles Anthony Graham Baker-Glenn, Wesley Peter Blackaby, Naimisha Trivedi
  • Publication number: 20140256725
    Abstract: The invention relates to FSH receptor antagonist according to general formula I or a pharmaceutically acceptable salt thereof and to a pharmaceutical composition containing the same. The compounds can be used for the treatment and prevention of endometriosis, for the treatment and prevention of pre-menopausal and peri-menopausal hormone-dependent breast cancer, for contraception, and for the treatment of uterine fibroids and other menstrual-related disorders.
    Type: Application
    Filed: September 14, 2012
    Publication date: September 11, 2014
    Inventors: Wesley Peter Blackaby, Martin De Kort, Mark Enthoven, Paul Stuart Hinchliffe, Christian Matthijs Poulie, Cornelis Marius Timmers, Saskia Vertaik
  • Patent number: 8681020
    Abstract: Methods and apparatus are provided for automated control of aerodrome lighting. An exemplary system includes a communication radio, an aerodrome lighting data source, and a processor. The communication radio is configured to selectively transmit radio frequency (RF) signals. The aerodrome lighting data source is configured to at least selectively supply aerodrome lighting data representative of light control characteristics of aerodrome lighting associated with individual aerodromes. The processor is in operable communication with the aerodrome lighting data source and the communication radio, and is configured to selectively retrieve, from the aerodrome lighting data source, aerodrome lighting data associated with an individual aerodrome, and selectively command the communication radio to transmit RF signals consistent with the light control characteristics associated with the individual aerodrome.
    Type: Grant
    Filed: December 9, 2011
    Date of Patent: March 25, 2014
    Assignee: Honeywell International Inc.
    Inventors: Sabu Mathew, Nithin Ambika, Wesley Peter, Swetha Balasa, Shashidhara Veerabhadraiah
  • Publication number: 20130226375
    Abstract: Systems and methods for updating a scale of a barometric altimeter on aircraft are provided. The method, for example, may include, but is not limited to, receiving, by an aircraft communication system, barometric altimeter scale data corresponding to an atmospheric pressure at an airport, determining, by the processor, if the altitude of the aircraft is below a transition level for the airport, and adjusting, by the processor, the scale of the barometric altimeter based upon the received barometric altimeter scale data when the altitude of the aircraft is below the transition level for the airport.
    Type: Application
    Filed: February 28, 2012
    Publication date: August 29, 2013
    Applicant: HONEYWELL INTERNATIONAL INC.
    Inventors: Wesley Peter, Sabu Mathew
  • Publication number: 20130147641
    Abstract: Methods and apparatus are provided for automated control of aerodrome lighting. An exemplary system includes a communication radio, an aerodrome lighting data source, and a processor. The communication radio is configured to selectively transmit radio frequency (RF) signals. The aerodrome lighting data source is configured to at least selectively supply aerodrome lighting data representative of light control characteristics of aerodrome lighting associated with individual aerodromes. The processor is in operable communication with the aerodrome lighting data source and the communication radio, and is configured to selectively retrieve, from the aerodrome lighting data source, aerodrome lighting data associated with an individual aerodrome, and selectively command the communication radio to transmit RF signals consistent with the light control characteristics associated with the individual aerodrome.
    Type: Application
    Filed: December 9, 2011
    Publication date: June 13, 2013
    Applicant: HONEYWELL INTERNATIONAL INC.
    Inventors: Sabu Mathew, Nithin Ambika, Wesley Peter, Swetha Balasa, Shashidhara Veerabhadraiah
  • Patent number: 8163956
    Abstract: A compound of the formula (I): wherein R1, R2, R3, R4, Ar, A, n and m are defined herein, is disclosed as a GlyT1 inhibitor; pharmaceutical compositions containing the compound of the formula (I) are also disclosed as are their use in medicine, for example in the treatment of schizophrenia.
    Type: Grant
    Filed: June 13, 2006
    Date of Patent: April 24, 2012
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Wesley Peter Blackaby, Ian Thomas Huscroft, Linda Elizabeth Keown, Richard Thomas Lewis, Piotr Antoni Raubo, Leslie Joseph Street, Christopher George Thomson, Joanne Thomson
  • Publication number: 20110098325
    Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain pyridine benzamide and pyrazine benzamide compounds (referred to herein as PDBA and PZBA compounds) which, inter alia, inhibit protein kinase D (PKD) (e.g., PKD1, PKD2, PKD3). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit PKD, and in the treatment of diseases and conditions that are mediated by PKD, that are ameliorated by the inhibition of PKD, etc., including proliferative conditions such as cancer, etc.
    Type: Application
    Filed: December 14, 2007
    Publication date: April 28, 2011
    Applicant: CANCER RESEARCH TECHNOLOGY LIMITED
    Inventors: Tony Michael Raynham, Timothy Robin Hammonds, Mark David Charles, Grégoire Alexandre Pave, Caroline Heather Foxton, Wesley Peter Blackaby, Adrian Philip Stevens, Chukuemeka Tennyson Ekwuru
  • Patent number: 7851638
    Abstract: The present invention provides compounds of formula I: wherein R1 is an alkyl, phenyl, heterocyclyl, cycloalkyl, alkoxy, ester, amino or amide group; R2 is a phenyl, heterocyclyl, alkyl, cycloalkyl or cycloalkylalkyl group; R3 is an alkyl, cycloalkyl, cycloalkylalkyl, amino or heterocyclyl group; R4 and R5 are hydrogen or alkyl or form a cycloalkyl ring; A is O or N; and m is zero or one; as inhibitors of GlyT1 and thus as useful for treating or preventing diseases such as schizophrenia; with the provision of pharmaceutical compositions, first and second medical uses and methods of treatment.
    Type: Grant
    Filed: October 1, 2009
    Date of Patent: December 14, 2010
    Assignee: Merck Sharp & Dohme Limited
    Inventors: Wesley Peter Blackaby, Jose Luis Castro Pineiro, Richard Thomas Lewis, Elizabeth Mary Naylor, Leslie Joseph Street